Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Markets
/
Switzerland
/
ETF market
/
NBTK
/
Analysis
INVESCO MARKETS PL
NBTK
BX Swiss
NBTK
BX Swiss
NBTK
BX Swiss
NBTK
BX Swiss
Market closed
Market closed
No trades
See on Supercharts
Overview
Analysis
Discussions
Technicals
Seasonals
Key stats
Assets under management (AUM)
308.35 M
CHF
Fund flows (1Y)
−225.08 M
CHF
Dividend yield (indicated)
—
Discount/Premium to NAV
−0.6%
About INVESCO MARKETS PL
Issuer
Invesco Ltd.
Brand
Invesco
Expense ratio
0.40%
Home page
etf.invesco.com
Inception date
Nov 7, 2014
Index tracked
NASDAQ / Biotechnology
Management style
Passive
ISIN
IE00BQ70R696
The Fund is a passively managed Exchange-Traded Fund (ETF), which aims to track the Total Return performance of the NASDAQ Biotechnology Index (the Index) 1, less fees, expenses and transaction costs.
Show more
Classification
Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Exchange-specific
Weighting scheme
Market cap
Selection criteria
NASDAQ - listed
Returns
1 month
3 months
Year to date
1 year
3 years
5 years
Price performance
—
—
—
—
—
—
NAV total return
—
—
—
—
—
—
What's in the fund
As of November 12, 2024
Exposure type
Stocks
Bonds, Cash & Other
Health Technology
Stocks
99.99%
Health Technology
98.26%
Commercial Services
1.37%
Health Services
0.36%
Bonds, Cash & Other
0.01%
Miscellaneous
0.01%
Cash
−0.00%
Stock breakdown by region
99%
0%
North America
99.96%
Europe
0.04%
Latin America
0.00%
Asia
0.00%
Africa
0.00%
Middle East
0.00%
Oceania
0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows